Bright Minds Biosciences Inc. (DRUG)
NASDAQ·Healthcare·Biotechnology
$58.02
-4.38%
Mkt Cap $596.82M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (7 analysts)
$163.67
Range $126.00 – $220.00
Implied Upside
+182.1%
Consensus $163.67 vs current $58.02